← Eichor
Condition: Immunity Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immunity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER
NA · 1 location(s) · Medical University of Graz · NCT07267000Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Phase 2 · 2 location(s) · University of Maryland, Baltimore · NCT06624839Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk
Phase N/A · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT05879965Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06821100Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT03913962Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer
Phase N/A · 1 location(s) · Lars Olaf Cardell · NCT07131566Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
Phase N/A · 1 location(s) · Mayo Clinic · NCT04232566Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT07130799Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT07347769Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
Phase 1 · 1 location(s) · Dalhousie University · NCT06827470Exploring the Cutaneous Immune Response to Skin Massage in Early Life
NA · 1 location(s) · King's College London · NCT07228728Antibiotics and Vaccine Immune Responses Study
Phase 4 · 1 location(s) · South Australian Health and Medical Research Institute · NCT06148025Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Phase 3 · 5 location(s) · Butantan Institute · NCT06891950A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06246968A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTp
Phase 3 · 10 location(s) · GlaxoSmithKline · NCT07596173Surviving Pneumonia
Phase N/A · 1 location(s) · Nordsjaellands Hospital · NCT03795662A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT04683679Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors
EARLY_Phase 1 · 1 location(s) · Peking University Cancer Hospital & Institute · NCT06454955Zn Supplementation in HIV Immunological Non Responders
NA · 1 location(s) · Parc de Salut Mar · NCT06612554The Role of Obesity in Severe COVID-19 Pathophysiology
NA · 1 location(s) · Franciscus Gasthuis · NCT06968442Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04794829Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NA · 2 location(s) · University of California, San Francisco · NCT04221893VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT06092333Neo-adjuvant Immunotherapy Master Trial for Localized Cancers
Phase 2 · 1 location(s) · UNICANCER · NCT07262489A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Phase N/A · 11 location(s) · BioMarin Pharmaceutical · NCT06305234Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
Phase 1/Phase 2 · 1 location(s) · All Natural Medicine Clinic, LLC · NCT04790240The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT01780168Comorbid Obesity and Depression With an Anti-inflammatory Medication
NA · 1 location(s) · King's College London · NCT06537921A Repository to Study Host-Microbiome Interactions in Health and Disease
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05656378OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NA · 1 location(s) · Gynaecologisch Oncologisch Centrum Zuid · NCT06611072
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.